Skip to main content
Caplight Logo









AsparaGlue

AsparaGlue

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://asparaglue.com

Last Round

Accelerator

May 2, 2023

Total Funding Raised

$200,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AsparaGlue operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was an Accelerator round in May 2023.

AsparaGlue is a surgical devices company that is a developer of a synthetic surgical adhesive platform intended to improve sealing and tissue repair in wet surgical environments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AsparaGlue Comparables

Compare AsparaGlue with similar companies based on industry and business-model similarity.

AsparaGlue comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Limax Biosciences
88%
COHESIVES Medical
78%
Johnson & Johnson
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AsparaGlue Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 2, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 1001% MoM, reaching 1K.

  • May 3, 2025

    Monthly visitors grew 119% MoM, reaching 1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

AsparaGlue Filings

Explore SEC and related filing metadata, where available.

AsparaGlue filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AsparaGlue's valuation, stock price, and market status.

Is AsparaGlue a public or private company?

AsparaGlue is a private company.

What is the current stock price of AsparaGlue?

AsparaGlue is a private company, so its shares have no public market price. Caplight tracks AsparaGlue's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AsparaGlue worth (valuation)?

Valuation information for AsparaGlue is not publicly available.

Can I buy AsparaGlue stock?

AsparaGlue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AsparaGlue's last funding round?

AsparaGlue's most recent funding round was Accelerator on May 2, 2023.

Who are the main investors in AsparaGlue?

Investor information for AsparaGlue is not publicly disclosed.

Will AsparaGlue IPO soon?

No public IPO plans have been announced for AsparaGlue.

How can I track AsparaGlue secondary market activity?

Caplight tracks bids, offers, and trades in AsparaGlue's shares on secondary markets.

Firmographic Details

HeadquartersBerkeley, California
Employee Range2
Year Founded2023
Last FundingMay 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?